Search

everythinglearnresearchcommunity

for

Search:↓

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

No link found between new male baldness genes and female hair loss.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Women with AGA have higher lipid levels, increasing heart disease risk.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Thyroid hormone may speed up wound healing and hair growth, but more research is needed to understand its role in skin repair and use as a treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.